Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Orectalip (Oxaliplatin) Combination in High-risk Stage-II Colorectal Cancer
NCT02284529Phase 4Completed
- Sponsor
- Sinphar Pharmaceutical
- Start
- Oct 2012
- Primary completion
- Aug 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of oxaliplatin in colorectal cancer (CRC), sponsored by Sinphar Pharmaceutical. Started Oct 2012; status: completed.
02
Drugs
oxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02284529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02284529.